GlassScriptPhysician profile
Roxanne P Latimer
NPI 1912980822
$1,740.90
in general payments reported to CMS, 2019-2025
23 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $275 · 2021: $238 · 2023: $345 · 2024: $354 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.65 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $393.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $283.55 | 2020-2025 | |
| Amarin Pharma, INC. | $162.20 | 2020-2021 | |
| Amgen INC. | $161.43 | 2019-2025 | Repatha, Otezla, Repatha |
| Dexcom, INC. | $136.49 | 2023-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $134.00 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $57.01 | 2020-2024 | Jardiance, Mounjaro |
| Janssen Pharmaceuticals, INC | $48.11 | 2021 | |
| Pfizer INC. | $42.37 | 2020-2025 | |
| Glaxosmithkline, LLC. | $41.25 | 2021-2025 | Trelegy Ellipta |
| Gilead Sciences, INC. | $38.90 | 2020 | |
| Xeris Pharmaceuticals, INC. | $38.07 | 2021-2023 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $37.70 | 2019 | |
| Sumitomo Pharma America, INC. | $23.82 | 2023 | Gemtesa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.50 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $20.43 | 2023 | Vivitrol |
| Sonex Health, INC. | $17.78 | 2025 | Sx-One Microknife |
| Exact Sciences Corporation | $17.05 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.35 | 2020 | |
| Currax Pharmaceuticals LLC | $13.25 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.69 | 2019 | |
| Allergan, INC. | $12.10 | 2019 | |
| Phathom Pharmaceuticals, INC. | $10.44 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxanne Latimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.